Lv2
170 积分 2020-08-14 加入
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
5小时前
待确认
ATR promotes clearance of damaged DNA and damaged cells by rupturing micronuclei
7个月前
已完结
CD155 is essential for skeletal muscle regeneration by regulating satellite cell proliferation and differentiation
7个月前
已完结
p53 induces TAP1 and enhances the transport of MHC class I peptides
8个月前
已完结
p53 at the crossroads of tumor immunity
8个月前
已完结
Approach to manuscript preparation and submission: How to get your paper accepted
8个月前
已完结
Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents
8个月前
已完结
PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications
8个月前
已完结
LATIFY: Phase 3 study of ceralasertib + durvalumab vs docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer that progressed on or after anti-PD-(L)1 and platinum-based therapy
9个月前
已完结
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment
9个月前
已完结
皖公网安备34019202002308
